These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724 [Abstract] [Full Text] [Related]
3. Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention. Halken S. Pediatr Allergy Immunol; 2004 Jun; 15 Suppl 16():4-5, 9-32. PubMed ID: 15125698 [Abstract] [Full Text] [Related]
4. Determinants of total and specific IgE in infants with atopic dermatitis. ETAC Study Group. Early Treatment of the Atopic Child. Pediatr Allergy Immunol; 1997 Nov; 8(4):177-84. PubMed ID: 9553982 [Abstract] [Full Text] [Related]
8. [Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study]. Silny W, Czarnecka-Operacz M. Pol Merkur Lekarski; 2006 Dec; 21(126):558-65. PubMed ID: 17405298 [Abstract] [Full Text] [Related]
9. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. Pajno GB, Caminiti L, Vita D, Barberio G, Salzano G, Lombardo F, Canonica GW, Passalacqua G. J Allergy Clin Immunol; 2007 Jul; 120(1):164-70. PubMed ID: 17543376 [Abstract] [Full Text] [Related]